Gao QL - Search Results

1

DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy.

Wang MJ, Xia Y, Gao QL. Wang MJ, et al. Among authors: gao ql. Curr Med Sci. 2024 Apr;44(2):261-272. doi: 10.1007/s11596-024-2859-1. Epub 2024 Apr 2. Curr Med Sci. 2024. PMID: 38561595 Review.

2

PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer.

Li X, Fang T, Xu S, Jin P, Zhou D, Wang Z, Li H, Yang Z, Chen G, Zheng X, Xia Y, Wei X, Zhang Z, Yang X, Wang Y, Gao Q. Li X, et al. NPJ Precis Oncol. 2021 Jun 9;5(1):49. doi: 10.1038/s41698-021-00189-w. NPJ Precis Oncol. 2021. PMID: 34108603 Free PMC article.

3

Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis.

Xu T, Liu J, Xia Y, Wang Z, Li X, Gao Q. Xu T, et al. Ann Med. 2021 Dec;53(1):916-928. doi: 10.1080/07853890.2021.1937694. Ann Med. 2021. PMID: 34134578 Free PMC article.

4

Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma.

Cao C, Yu R, Gong W, Liu D, Zhang X, Fang Y, Xia Y, Zhang W, Gao Q. Cao C, et al. Aging (Albany NY). 2021 Nov 27;13(22):24686-24709. doi: 10.18632/aging.203710. Epub 2021 Nov 27. Aging (Albany NY). 2021. PMID: 34837690 Free PMC article.

5

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer.

Xu T, Wang Z, Liu J, Wang G, Zhou D, Du Y, Li X, Xia Y, Gao Q. Xu T, et al. Front Oncol. 2022 Jun 8;12:820696. doi: 10.3389/fonc.2022.820696. eCollection 2022. Front Oncol. 2022. PMID: 35756622 Free PMC article.

6

Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review).

Jin N, Xia Y, Gao Q. Jin N, et al. Int J Oncol. 2023 Feb;62(2):28. doi: 10.3892/ijo.2023.5476. Epub 2023 Jan 5. Int J Oncol. 2023. PMID: 36601757 Free PMC article. Review.

7

Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB-Triggered SASP in Cancer-Associated Fibroblasts.

Jin P, Li X, Xia Y, Li H, Li X, Yang ZY, Wang Z, Xu C, Fang T, Zhou D, Xiong X, Wang SY, Xu S, Gao Q. Jin P, et al. Mol Cancer Ther. 2023 Apr 3;22(4):447-458. doi: 10.1158/1535-7163.MCT-22-0396. Mol Cancer Ther. 2023. PMID: 36780236

8

Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor.

Wang S, Xia Y, Huang P, Xu C, Qian Y, Fang T, Gao Q. Wang S, et al. J Oncol. 2023 Feb 6;2023:1453739. doi: 10.1155/2023/1453739. eCollection 2023. J Oncol. 2023. PMID: 36793373 Free PMC article.

9

Macrophages facilitate tumor cell PD-L1 expression via an IL-1β-centered loop to attenuate immune checkpoint blockade.

Xu C, Xia Y, Zhang BW, Drokow EK, Li HY, Xu S, Wang Z, Wang SY, Jin P, Fang T, Xiong XM, Huang P, Jin N, Tan JH, Zhong Q, Chen YX, Zhang Q, Fang Y, Ye F, Gao QL. Xu C, et al. Among authors: gao ql. MedComm (2020). 2023 Mar 30;4(2):e242. doi: 10.1002/mco2.242. eCollection 2023 Apr. MedComm (2020). 2023. PMID: 37009412 Free PMC article.

10

Integrated analysis identifies RAC3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.

Huang P, Qian Y, Xia Y, Wang S, Xu C, Zhu X, Gao Q. Huang P, et al. J Cell Mol Med. 2023 Aug;27(16):2385-2397. doi: 10.1111/jcmm.17824. Epub 2023 Jun 29. J Cell Mol Med. 2023. PMID: 37386813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters